PMID: 11904958Mar 22, 2002Paper

Overview of recent monoclonal antibody therapy

Nihon rinsho. Japanese journal of clinical medicine
Itaru Ozeki, Kohzoh Imai

Abstract

It has been 27 years since Milstein and Köhler stunned the world of biology by announcing the discovery of monoclonal antibodies. Novel MoAb improved forms of chimeric and humanized antibodies with high antigen-binding affinities are currently being developed by both genetic and chemical methods. The rapid growth of molecular techniques will permit the development of novel antibodies, which should significantly improve conventional therapeutic strategies. This report overviews recent advances in the field of monoclonal antibodies and provides insight regarding the promises and limitations of this novel therapeutic approach.

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The American Journal of the Medical Sciences
A F LoBuglio, M N Saleh
Médecine sciences : M/S
Friedrich Lackner, Marie-Emmanuelle Behr-Gross
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
S SiberilJ-L Teillaud
BioTechniques
J V Gavilondo, J W Larrick
© 2022 Meta ULC. All rights reserved